AB
CCXI

Amalgamated Bank’s ChemoCentryx, Inc. CCXI Stock Holding History

Amalgamated Bank’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-9,672
Closed -$500K – 2992
2022
Q3 		$500K Buy
9,672
+202
+2% +$8.35K ﹤0.01% 1437
2022
Q2 		$235K Buy
9,470
+2,801
+42% +$61.7K ﹤0.01% 1805
2022
Q1 		$167K Sell
6,669
-529
-7% -$14.9K ﹤0.01% 2010
2021
Q4 		$262K Buy
+7,198
New +$253K ﹤0.01% 1881
2021
Q2 		– Sell
-7,060
Closed -$362K – 2186
2021
Q1 		$362K Sell
7,060
-690
-9% -$41.5K 0.01% 1166
2020
Q4 		$480K Buy
7,750
+41
+0.5% +$2.35K 0.02% 991
2020
Q3 		$422K Buy
7,709
+595
+8% +$32K 0.02% 932
2020
Q2 		$409K Sell
7,114
-78
-1% -$4.25K 0.02% 943
2020
Q1 		$289K Sell
7,192
-147
-2% -$6.24K 0.01% 1172
2019
Q4 		$290K Buy
+7,339
New +$129K 0.01% 1426

Other funds holding CCXI

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Amalgamated Bank's CCXI Position: Q4 2022 in Review

Amalgamated Bank sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 9,672 shares — an estimated $500K sold.

Amalgamated Bank first reported a position in CCXI in Q4 2019 and held it in 10 quarters. The position peaked at $500K in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Amalgamated Bank reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Amalgamated Bank sold 9,672 ChemoCentryx, Inc. shares in Q4 2022, an estimated $500K.
  • Amalgamated Bank first reported a position in ChemoCentryx, Inc. in Q4 2019 and held it in 10 quarters.
  • Amalgamated Bank's ChemoCentryx, Inc. position peaked at $500K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Amalgamated Bank's 13F filing for Q4 2022, filed 10 Feb 2023.